KPIs & Operating Metrics(New)
Growth Metrics

Tenet Healthcare (THC) Return on Sales (2016 - 2026)

Tenet Healthcare (THC) has disclosed Return on Sales for 17 consecutive years, with 0.17% as the latest value for Q1 2026.

  • For Q1 2026, Return on Sales rose 5.0% year-over-year to 0.17%; the TTM value through Mar 2026 reached 0.12%, up 1.0%, while the annual FY2025 figure was 0.11%, 9.0% down from the prior year.
  • Return on Sales hit 0.17% in Q1 2026 for Tenet Healthcare, up from 0.12% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.43% in Q1 2024 and bottomed at 0.0% in Q4 2022.
  • Average Return on Sales over 4 years is 0.12%, with a median of 0.11% recorded in 2024.
  • Year-over-year, Return on Sales crashed -32bps in 2025 and then increased 5bps in 2026.
  • Tenet Healthcare's Return on Sales stood at 0.0% in 2022, then surged by 216094bps to 0.11% in 2024, then increased by 3bps to 0.12% in 2025, then skyrocketed by 45bps to 0.17% in 2026.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.17%, 0.12%, and 0.11% for Q1 2026, Q4 2025, and Q3 2025 respectively.